Skip To Content
Nathalie Beauregard

Nathalie Beauregard

Partner, Corporate


Contact Information

nbeauregard@osler.com

tel: 514.904.8121

Office

Montréal

Bar Admission

Québec, 1989

New York, 1989

Education
  • HEC (Paris) and New York University (Stern), M.B.A.
  • McGill University, B.C.L., LL.B.
Language(s)
English, French

Nathalie is a partner in the Corporate Practice Group. She has close to 30 years of experience during which she has devoted most of her time helping companies to get established and grow through various development stages. Nathalie is a founding member of Réseau Anges Québec. Her interests lie in the technology space and she has developed a passion for artificial intelligence, life sciences and green tech in particular. She has built a strong network in those areas, in which she is very active. Nathalie’s clients can benefit from her deep knowledge of these industries and the major players.

Nathalie’s practice focuses on domestic and cross-border mergers and acquisitions, financing, venture capital, government contracts, joint ventures, licensing and collaboration agreements.

Nathalie also serves as de-facto counsel to Canadian technology privately held companies providing general business advice on various matters such as raising capital and financing, negotiating commercial agreements, executing employment law and IP.

She also advises prominent international companies, including franchise systems, on many aspects of their operations.

Nathalie has received significant industry recognition, including recognition from Best Lawyers and Lexpert where she is listed and repeatedly recommended in the Biotechnology and Information Technology areas.

  • Katana Biopharma

    Katana Biopharma in its acquisition by Theratechnologies

  • Boralex

    Roncevaux and Plateau II, in connection with Boralex’s acquisition of Invenergy’s Québec projects

  • Milestone Pharmaceuticals Inc.

    Milestone Pharmaceuticals Inc. in its US$80 million Series D Private Financing

  • Angiochem Inc.

    Angiochem Inc. in its Series C financing round of $7.5 million

  • Inversago Pharma

    Genesys Capital in Inversago Pharma's $7 million Series A financing

  • Concentric Agriculture Inc.

    Concentric Agriculture Inc. (previously: Inocucor Technologies Inc.), in its acquisition of ATP Nutrition Inc.

  • KalGene Pharmaceuticals Inc.

    KalGene Pharmaceuticals Inc. in its Series A Financing round (second tranche) of $1.67 million

  • immun.io Inc.

    immun.io Inc. in its sale to Trend Micro

  • Imagia Cybernetics Inc.

    Imagia Cybernetics Inc. in its acquisition of Cadens Medical Imaging

  • Milestone Pharmaceuticals Inc.

    Milestone Pharmaceuticals Inc., in connection with the first tranche closing of a Series C financing led by Novo Holdings A/S

  • Concentric Agriculture Inc.

    Concentric Agriculture Inc. (previously: Inocucor Technologies Inc.), in connection with the first tranche closing of a Series B financing led by TPG ART

    • Represented and advised a number of companies in the industry of life sciences particularly in the context of their mergers, fundings, strategic alliances and other agreements related to their clinical studies and research agreements;
    • Represented and advised a number of companies that develop and market clean technologies as part of their financing, marketing and joint venture agreements.
    • Represented several domestic and foreign investment funds as part of various risk capital investments in the technology and life sciences sectors;
    • Negotiated complex strategic alliances between major players in the video game industry;
    • Represented online service providers on issues related to cross-border data on public sector clients;
    • Advised clients in connection with many government procurement topics, including integration projects;
    • Represented clients in connection with various online services including computer data protection and management and control tools;
    • Represented Anges Québec and Accelerateur de création d’entreprises through the creation of their funds;
    • Represented intermunicipal boards of municipalities as part of tender process for the creation of limited partnerships and the creation of such partnerships for the operation of wind farms in Quebec and for the negotiation of commercial agreements;
  • Find More

Lexpert

  • The Canadian Legal Lexpert Directory, 2014-2019: Technology Transactions
  • The Canadian Legal Lexpert Directory, 2014-2018: Biotechnology

Best Lawyers

  • The Best Lawyers in Canada, 2016-2019, Biotechnology Law; Information Technology Law

  • Accélérateur de création d'entreprises technologiques (" ACET "), Board member.
  • Réseau Anges Québec, Board of Directors, 2008 to 2012.
  • Galerie d’art d'Outremont; Board Member and Vice-President, 2011 to 2018.
  • Arion Baroque Orchestra, Ambassador.
  • Fondation du Barreau du Québec and Fondation de recherche en administration de l’Université de Sherbrooke, Governor.
  • Fondation Armand-Frappier; member of the Organization Committee for 2014 and 2018 “Fête Champêtre.”

  • Canadian Bar Association
  • Association of Québec Women in Financial
  • Canadian Venture Capital Association
  • Canadian Information Technologies Law Association

  • Nathalie participated on April 19, 2018 in a Venture Capital Panel: Four Ingredients of Success organized by JMSB Alumni & YCIF.
  • Nathalie gave on February 20, 2017 a conference on “Innovation and Entrepreneurship. Will Montreal be the next Silicon Valley?” organized by McGill Law Journal.
  • Nathalie gave on November 2, 2015 a conference on “Limitations of Liability Provisions” organized by Osler/ACC.
  • Internet and E-Commerce Law in Canada, volume 14, no. 11, March 2014: "Can you carry out Bitcoins activities in Canada without legal risks?"
  • Osler Insights: A Blog on Technology, Innovation and Outsourcing, December 17, 2013 – “Can you carry out Bitcoins activities in Canada without legal risks ”.
  • Nathalie gave on November 5, 2013 a conference - on “Mergers and Acquisitions Transactions : The Perspective of a Venture Capital Investor " organized by Osler/ACC.
  • Nathalie gave on February 21, 2011 a conference at the University of Sherbrooke (MBA / Entrepreneurship) , on “ Cours introductif sur le droit des compagnies ” and was speaker at “ Journées d’études fiscales “ organized by the Canadian Tax Foundation, McGill University and the Canadian Bar Association in June 2010 on “ Les conventions entre actionnaires, aspects corporatifs et fiscaux “ . The text of the conference has been published by the Canadian Tax Foundation in TaxFind Online.
  • Osler Review – Franchise Review, November 12, 2009. “National Assembly introduces Integrity in Public Contracts Act ”.
  • Osler Review – Franchise Review, October 2009. “The Charter of the French language and websites”.
  • Nathalie regularly gives workshops on term sheets for group of investors.